Concepedia

Christopher Garris

CG

Statistics

Publications

30

Citations

6.6K

H-Index

23

Active since

2010

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Center for Systems Biology

Swiss Cancer Center Léman

University of Geneva

Christopher Garris is an author at Massachusetts General Hospital specializing in immunology, oncology, and cancer immunotherapy.

Publications per year

2010–2025

30

Publications

30

TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy

Christopher B. Rodell, Sean P. Arlauckas, Michael F. Cuccarese et al. · Nature Biomedical Engineering · 2018 · 1.1K citations

Medicine, Immunology, Oncology +16

Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy

Christina Pfirschke, Camilla Engblom, Steffen Rickelt et al. · Immunity · 2016 · 950 citations · Full text

Medicine, Immunology, Oncology +14

Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

Christopher Garris, Sean P. Arlauckas, Rainer H. Köhler et al. · Immunity · 2018 · 937 citations · Full text

Medicine, Immunology, Oncology +12

In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy

Sean P. Arlauckas, Christopher Garris, Rainer H. Köhler et al. · Science Translational Medicine · 2017 · 653 citations · Full text

Life Sciences, Immunology, Oncology +17

A neutrophil response linked to tumor control in immunotherapy

Jeremy Gungabeesoon, Nicolas A. Gort-Freitas, Máté Kiss et al. · Cell · 2023 · 388 citations · Full text

Life Sciences, Immunology, Oncology +12

1–5 of 30